Glaxo to Pay $750 Million in Adulterated Drugs Case

28.10.2010 - GlaxoSmithKline has agreed to pay $750 million and plead guilty to manufacturing and distributing adulterated drugs from a now closed plant in Puerto Rico, the U.S. Justice...